Genetic mutations that prevent pain: implications for future pain medication.
about
Exploring Genetic Susceptibility to FibromyalgiaNeurological diseases and painAnimal models of chronic pain: Advances and challenges for clinical translation.Tolerance and withdrawal from prolonged opioid use in critically ill children.Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research.Low back pain in older adults: risk factors, management options and future directions.Novel diagnostic and prognostic methods for disc degeneration and low back painIn search of analgesia: emerging roles of GPCRs in pain.Pharmacogenetics of new analgesics.Genomics and pain research in sickle cell disease: an explanation of heterogeneity?The delta opioid receptor: an evolving target for the treatment of brain disorders.Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.Translating the human genome to manage pediatric postoperative pain.Pain sensitivity and opioid analgesia: a pharmacogenomic twin studyHuman pain and genetics: some basicsPolymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain.Current evidence for a modulation of low back pain by human genetic variants.Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis.Genetic variability of pain perception and treatment--clinical pharmacological implications.Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade.MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentationGenetics of chronic post-surgical pain: a crucial step toward personal pain medicine.Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA.The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia.Genetic susceptibility to postherniotomy pain. The influence of polymorphisms in the Mu opioid receptor, TNF-α, GRIK3, GCH1, BDNF and CACNA2D2 genes.New insights into the genetics of fibromyalgia.
P2860
Q26797418-4F084C67-B5F4-442F-9EC5-C8EBDAF03B8BQ26822891-4148AE49-2D7A-442C-B96E-ACBB0F6F8BA4Q30249165-345A8048-1ACE-4965-BA72-0FFADE234A79Q30428413-198AE780-BC67-4DEA-8905-7BF0FFDD2573Q30443497-825397F1-CC1A-4CC6-9659-80C997648C95Q33576918-92A3D220-D03A-4EB3-A615-B37CDAF2A1B2Q33806592-D3916332-A866-4EFB-88D4-91D888B9AC23Q33819256-68724E3A-3E17-4041-BDF1-3185AE70310FQ35005640-74EF2D9E-75CD-48E9-B466-0F48189DAED8Q35137080-9690289D-330E-4FAF-AB87-C8A09377EDE2Q35400738-D3705C71-517F-4B67-BC48-10BE23858A9CQ35539662-85A3A317-9363-4DB9-AB1D-58424E6E76A5Q35654256-DBEC34BF-6DD5-4033-860E-A2E5345307ABQ36040669-3AB1235C-FE65-40FA-B89C-EB75B37E33F0Q36110585-68DA7B89-63E1-4E3A-B646-9D0B085CD077Q37275941-22F13032-9274-4B49-97FC-DE57BC2D4BE2Q37396519-B10B6DE1-51C2-485F-ADBC-D20519B0BEDFQ37803223-69A863CA-DC46-4866-89BE-0CAA5AECD0C1Q37846139-4964F182-0FC6-45AE-88B9-7BE57A4F1ED5Q38088356-F1FCDF10-4B79-457C-B225-DA5995E4BAC9Q38210121-B7B0CCAE-D1F2-4C6E-9715-1ECA5919204BQ38282574-DFDA3471-57DA-4353-A91A-4237871940F8Q39068391-926DDC34-374D-44BA-92FD-60AD9EA573B5Q44334036-F4D06FDC-6AA6-4324-A1EF-EF2B746BC5FFQ44348473-8DACA154-D096-4819-BBB9-460DE5F0C3BFQ45957029-C7D5402C-3DC7-4BFD-AF91-13757120DA46
P2860
Genetic mutations that prevent pain: implications for future pain medication.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic mutations that prevent pain: implications for future pain medication.
@en
Genetic mutations that prevent pain: implications for future pain medication.
@nl
type
label
Genetic mutations that prevent pain: implications for future pain medication.
@en
Genetic mutations that prevent pain: implications for future pain medication.
@nl
prefLabel
Genetic mutations that prevent pain: implications for future pain medication.
@en
Genetic mutations that prevent pain: implications for future pain medication.
@nl
P2860
P356
P1433
P1476
Genetic mutations that prevent pain: implications for future pain medication.
@en
P2093
Bruno Oertel
P2860
P304
P356
10.2217/14622416.9.2.179
P50
P577
2008-02-01T00:00:00Z